Telehealth General Psychiatry Prescribing: What PMHNPs Can Do in Georgia

If you’re a psychiatrist or PMHNP exploring telehealth, you’ve probably asked yourself: Can I actually prescribe medications—especially controlled substances—through a video visit? The short answer: Yes, but the rules depend on where you’re licensed and what medications you’re prescribing.

The regulatory landscape for telepsychiatry prescribing has evolved dramatically since 2020. Federal waivers eliminated the in-person exam requirement for controlled substances, states have clarified their telehealth laws, and reimbursement has reached near-parity with in-person care. But navigating this patchwork of federal DEA rules, state-specific scope-of-practice laws, and NP vs. MD authority differences can feel overwhelming.

This guide breaks down exactly what psychiatrists and psychiatric nurse practitioners can prescribe via telehealth in 2026, how the rules differ by state (focusing on California, Texas, Florida, New York, Pennsylvania, and Illinois), and what you need to know about reimbursement, compliance, and building a sustainable telepsychiatry practice.

The Federal Framework: DEA Waivers and the Ryan Haight Act

Before diving into state-specific rules, let’s establish the federal baseline. The Ryan Haight Online Pharmacy Consumer Protection Act (2008) originally required an in-person medical evaluation before prescribing controlled substances (Schedules II-V). For psychiatry—where stimulants for ADHD, benzodiazepines for anxiety, and buprenorphine for opioid use disorder are routine—this was a massive barrier to telehealth.

Here’s what changed:

During the COVID-19 public health emergency, the DEA issued temporary waivers allowing providers to prescribe controlled substances via telehealth without an initial in-person visit. These flexibilities have been extended through December 31, 2025, meaning as of early 2026, psychiatrists can still initiate controlled substance prescriptions (like Adderall, Xanax, or Suboxone) through a telemedicine evaluation (texasnp.org, natlawreview.com).

What’s uncertain:

The DEA has proposed permanent rules that could reimpose some in-person requirements—such as limiting initial teleprescriptions to 30-day supplies or requiring a referral from a provider who saw the patient in person. As of early 2026, those permanent rules are still pending. Stay alert: The DEA could finalize regulations by late 2024 or early 2025 that change the current flexibility (nixonpeabody.com).

Practical takeaway for psychiatrists:

Right now, you can start a new patient on a Schedule II stimulant (e.g., methylphenidate for ADHD) or a benzodiazepine (e.g., clonazepam for panic disorder) via a telehealth visit, as long as you establish a legitimate patient-provider relationship through real-time audio-visual interaction. This applies nationwide under federal law. State laws may add extra layers, which we’ll cover next.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Telehealth Prescribing Rules

Federal law sets the floor, but states can impose additional restrictions—or, in some cases, explicitly permit teleprescribing where federal rules are ambiguous. Here’s how the priority states handle telehealth prescribing for psychiatry:

California: Telehealth-Friendly with a ‘Good Faith Exam’ Standard

California allows psychiatrists to prescribe medications (including controlled substances) via telehealth as long as a ‘good faith prior examination’ is conducted. Critically, California law explicitly recognizes that a telehealth evaluation qualifies as this exam (natlawreview.com).

What this means:

• You can initiate psychiatric medications—including Schedule II stimulants—after a thorough video consultation.
• You must check California’s Prescription Drug Monitoring Program (CURES) before prescribing Schedule II-IV medications, and at least once every four months for ongoing controlled substance therapy.
• Private insurers in California are required to reimburse telehealth services at parity with in-person visits (AB 744, 2019).

For PMHNPs:California is transitioning to full practice authority for experienced NPs. As of 2023, NPs with three years of experience can practice in collaborative settings without direct physician supervision (103 NP certification). By January 1, 2026, experienced NPs can apply for 104 NP certification, which grants full independent practice—including prescribing controlled substances—without any physician oversight (rn.ca.gov). Until then, newer NPs must work under physician-supervised standardized procedures.

Texas: Mental Health Exception, But Heavy NP Restrictions

Texas allows telemedicine prescribing if the standard of care is met and the encounter involves two-way, real-time audio-visual communication (cchpca.org). There’s one important carve-out: Texas prohibits teleprescribing controlled substances for chronic pain management (you must see the patient in person). However, psychiatric treatment is exempt from this restriction.

What this means:

• A Texas-licensed psychiatrist can prescribe stimulants for ADHD or anxiolytics for acute anxiety via telehealth, under the current federal DEA waiver.
• You must check the Texas Prescription Monitoring Program (PMP) before prescribing any controlled substance.
• Texas law requires that telemedicine encounters meet the same standard of care as in-person visits, including adequate patient evaluation and emergency protocols (cchpca.org).

For PMHNPs:Texas is a restricted practice state. PMHNPs cannot prescribe independently—they must have a Prescriptive Authority Agreement with a supervising physician (bon.texas.gov). Even with an agreement, Texas NPs are generally prohibited from prescribing Schedule II controlled substances in outpatient settings except in very limited cases (like terminal illness) (cchpca.org). This means Texas PMHNPs typically rely on their supervising psychiatrist to write initial stimulant prescriptions for ADHD patients, even via telehealth.

Bottom line: If you’re a psychiatrist, Texas is workable for telepsychiatry. If you’re a PMHNP, you’ll need a collaborating physician and significant restrictions on controlled substance prescribing.

Florida: Explicit Permission for Psychiatric Telehealth Prescribing

Florida is one of the few states with explicit statutory language allowing controlled substance prescribing via telehealth specifically for psychiatric treatment. Florida Statutes (FS 456.47 and 464.012) permit teleprescribing of controlled substances for:

• Treatment of psychiatric disorders
• Inpatient hospital care
• Hospice and nursing home residents

The only prohibition is prescribing controlled substances for chronic non-malignant pain via telehealth (which requires an in-person exam) (flsenate.gov).

What this means:

• A Florida-licensed psychiatrist can initiate ADHD stimulants, benzodiazepines, or buprenorphine for psychiatric indications through a telehealth visit—this is explicitly legal under state law, independent of federal waivers.
• You must still comply with standard-of-care requirements (thorough evaluation, emergency protocols, PMP checks).

For PMHNPs:Florida is a restricted state for psychiatric NPs. While Florida passed HB 607 (2020) allowing some NPs to practice autonomously in primary care, psychiatric NPs were excluded from this independence (npschools.com).

Florida PMHNPs must practice under a supervising physician’s protocol. However, Florida law does define a special category: ‘psychiatric nurse’ (a PMHNP with at least two years of psychiatric experience under a psychiatrist). Psychiatric nurses can prescribe psychotropic controlled substances in collaboration with a psychiatrist, and they’re exempt from the 7-day Schedule II limit that applies to other NPs (flsenate.gov).

Bottom line: Florida explicitly supports telepsychiatry prescribing for MDs. PMHNPs need a collaborating psychiatrist but can prescribe psychotropics with fewer restrictions than other NP specialties.

New York: Recently Aligned State Rules with Federal Flexibility

New York has traditionally required an in-person exam for controlled substance prescriptions, but the state recently finalized regulations that align with federal DEA waivers. As of mid-2025, New York explicitly permits controlled substance prescribing via telehealth when consistent with federal law (nixonpeabody.com).

What this means:

• New York psychiatrists can prescribe controlled medications via telehealth under the current DEA waiver without fear of state-level non-compliance.
• If the DEA finalizes rules requiring some in-person visits, New York’s regulations will likely incorporate similar exceptions (e.g., allowing teleprescribing if another provider conducted an in-person exam in the past 12 months).
• New York requires psychiatrists to use e-prescribing for all controlled substances (no paper scripts) and to check the state’s PMP registry (I-STOP law).

For PMHNPs:New York has a transition-to-independence model. New PMHNPs must work under a written collaborative agreement with a physician for their first 3,600 hours of practice (about two years full-time) (jdsupra.com). After meeting this threshold, they can practice independently—no written agreement or chart review required—though they must maintain a ‘collaborative relationship’ (informal physician contacts for referrals).

This means experienced PMHNPs in New York can prescribe controlled substances via telehealth on the same basis as psychiatrists. New graduates will need a collaborating psychiatrist initially.

Pennsylvania: Collaboration Required for NPs, But Telehealth is Supported

Pennsylvania allows telehealth prescribing of controlled substances in line with federal rules—there’s no state-specific ban on teleprescribing for psychiatric treatment. Psychiatrists can prescribe freely via telehealth.

For PMHNPs:Pennsylvania is a reduced practice state with no pathway to full independence. PMHNPs must maintain a collaborative agreement with a physician indefinitely (pacnp.org).

The agreement must specify which medications the NP can prescribe. For Schedule II controlled substances, Pennsylvania limits NPs to a 30-day supply for initial prescriptions, and the supervising physician must be notified within 24 hours (pacnp.org).

Bottom line: Pennsylvania supports telepsychiatry for MDs. PMHNPs will need a collaborative agreement and face some controlled substance restrictions.

Illinois: Pathway to Independence After Transition Period

Illinois allows telehealth prescribing under the same standard as in-person care. The state enacted strong telehealth parity laws (SB 667, 2021) requiring private insurers to reimburse telehealth at the same rate as in-person visits through at least 2027.

For PMHNPs:Illinois offers a transition to full practice authority. New PMHNPs must work under a Written Collaborative Agreement with a physician for 4,000 hours (about two years) plus complete 250 hours of continuing education in advanced pharmacology (nursepractitionerlicense.com).

After meeting these requirements, they can apply for Full Practice Authority, allowing independent prescribing of all medications, including Schedule II-V controlled substances.

Bottom line: Illinois psychiatrists have full telehealth prescribing authority. PMHNPs can achieve independence after a transition period, then practice on the same basis as psychiatrists.

PMHNP vs. Psychiatrist Prescribing Authority: A Quick Comparison

Key takeaway: Psychiatrists have unrestricted prescribing authority in all states. PMHNPs face varying levels of restriction depending on state law—from near-parity (NY, CA after 2026) to significant limitations (TX, FL, PA).

Reimbursement for Telepsychiatry Medication Management

One of the most common questions from psychiatrists considering telehealth: Will I get paid the same as in-person visits?

The short answer: Yes, in most cases.

Medicare Reimbursement (2026 Rates)

Medicare has permanently extended telehealth coverage for mental health services, with near-total parity for reimbursement. Here are the national average rates for common psychiatric billing codes:

(therathink.com, therathink.com)

For PMHNPs: Medicare reimburses nurse practitioners at 85% of the physician rate when billed under the NP’s own NPI (nursepractitioneronline.com). So a 99213 billed by an NP would be ~$81 instead of $95.

Private Insurance

Commercial insurance rates vary by region and payer, but typically exceed Medicare rates. For example:

• A major insurer might pay $150 for a 99213 and $200 for a 99214 in a high-cost market.
• About half of U.S. states have enacted telehealth payment parity laws for behavioral health, meaning insurers must reimburse telehealth visits at the same rate as in-person.

Examples of strong parity states:

• California: AB 744 (2019) requires payment parity for telehealth.
• Illinois: SB 667 (2021) mandates equal reimbursement through 2027.
• New York: Updated telehealth coverage laws in 2021 to ensure parity.

Texas does not mandate payment parity, but most major insurers voluntarily pay equal rates for tele-mental health due to high demand.

Medicaid

Medicaid rates are generally lower than Medicare, but many state Medicaid programs have expanded telehealth reimbursement:

• New York Medicaid reimburses tele-mental health at the same rate as face-to-face.
• Pennsylvania Medicaid expanded permanent telehealth coverage with parity.
• California Medi-Cal historically paid ~75% of Medicare rates but has invested in raising behavioral health reimbursement.

Audio-Only Telehealth

Medicare and some state Medicaid programs now reimburse audio-only telehealth for mental health services (for patients without video access). As of 2022, Medicare pays the same rate for audio-only mental health follow-ups as for video visits (aapp.org). States like Massachusetts and Illinois have similar requirements for private insurers.

Compliance Essentials: What You Must Do

Even with favorable laws, staying compliant is critical. Here’s your checklist:

For All Psychiatrists:

1. Licensure: You must be licensed in the state where the patient is located at the time of the visit. Use the Interstate Medical Licensure Compact (IMLC) if available (TX, PA, IL are members; CA, NY, FL are not).
2. DEA Registration: You need a DEA number in the state where you’re prescribing controlled substances. (Federal law allows a single DEA registration to cover telehealth prescribing to patients in other states, as long as you’re licensed in those states.)
3. Prescription Monitoring Program (PMP) Checks: Most states (including CA, TX, FL, NY, PA, IL) require checking the state PMP before prescribing Schedule II-IV medications.
4. E-Prescribing: Some states (like NY) mandate electronic prescribing for controlled substances—no paper scripts allowed.
5. Standard of Care: Conduct the same thorough evaluation you would in-person: detailed history, mental status exam, patient consent, emergency protocols.
6. Documentation: Document that the visit was conducted via telehealth, include the patient’s location, verify their identity, and obtain informed consent for telemedicine.

For PMHNPs:

• Collaborative Agreements: If your state requires one (TX, FL, PA, or IL before FPA), ensure it’s current, filed with the appropriate board, and specifies your prescriptive authority.
• Scope of Practice: Know your state’s limits on Schedule II prescribing (e.g., 30-day caps in PA, outpatient bans in TX).
• Chart Reviews: Some states require your collaborating physician to review a percentage of your charts—stay compliant with these requirements.

The Business Case: Why Telepsychiatry Makes Economic Sense

Let’s address the elephant in the room: patient acquisition costs and platform economics.

Many psychiatrists avoid traditional marketing because it’s expensive and uncertain. Here’s the reality:

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.
• Google Ads for mental health keywords cost $15-40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+.
• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+), but when you factor in monthly subscription costs, the total adds up.
• When you calculate ALL costs—agency fees, ad spend testing, staff time to qualify leads, no-show rates from cold leads, and failed campaigns—acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+.

Klarity Health’s pay-per-appointment model removes this risk entirely.

Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. gambling on marketing channels.

Here’s what makes Klarity different:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

For providers starting out or scaling, a platform that handles patient acquisition removes the risk entirely. Instead of wondering if your next $500 in Google Ads will generate a single patient, you know exactly what you’re paying per booked appointment.

FAQ: Telepsychiatry Prescribing

Q: Can I prescribe Adderall or other Schedule II stimulants via telehealth in 2026?
A: Yes, under the current federal DEA waiver (extended through December 31, 2025). This applies in all states, though some have additional requirements. Check your state’s specific rules and stay updated on pending DEA regulations.

Q: Do I need to see a patient in person before prescribing controlled substances via telehealth?
A: Not currently, under federal law. The DEA waiver eliminates the in-person exam requirement. However, this could change if the DEA finalizes permanent rules in late 2024 or 2025.

Q: Can PMHNPs prescribe the same medications as psychiatrists via telehealth?
A: It depends on the state. In full practice authority states (or after meeting experience requirements in NY, IL, CA), PMHNPs can prescribe independently, including controlled substances. In restricted states (TX, FL, PA), PMHNPs face significant limitations and require physician collaboration.

Q: Will I get paid the same for telehealth visits as in-person?
A: In most cases, yes. Medicare pays the same rates for telehealth and in-person mental health services. About half of U.S. states have telehealth payment parity laws for private insurance. Check your state’s specific laws.

Q: Can I prescribe buprenorphine (Suboxone) for opioid use disorder via telehealth?
A: Yes. The federal X-waiver requirement was eliminated in 2023, and buprenorphine can be prescribed via telehealth under the DEA waiver. You must be licensed in the patient’s state and follow standard prescribing practices.

Q: What documentation do I need for telehealth prescribing?
A: Document the same information as an in-person visit: patient history, mental status exam, diagnosis, treatment plan, and medication rationale. Also note that the visit was conducted via telehealth, the patient’s location, informed consent, and emergency protocols.

Q: Can I practice telepsychiatry across state lines?
A: Only if you’re licensed in each state where your patients are located. The Interstate Medical Licensure Compact (IMLC) can expedite obtaining licenses in member states (TX, PA, IL are members; CA, NY, FL are not).

Ready to Build Your Telepsychiatry Practice?

The regulatory environment for telepsychiatry prescribing in 2026 is more favorable than ever. Federal waivers allow controlled substance prescribing via telehealth, most states have clarified their rules, and reimbursement has reached parity with in-person care.

If you’re a psychiatrist or PMHNP looking to expand your practice without the headaches of marketing, patient acquisition, and platform management, Klarity Health offers a solution: pre-qualified patients, built-in telehealth infrastructure, and a pay-per-appointment model that eliminates upfront risk.

Instead of spending months and thousands of dollars hoping your marketing generates patients, you can start seeing patients immediately—and only pay when they book.

Ready to join Klarity’s provider network? Visit Klarity Health to learn more about how we match psychiatrists and PMHNPs with patients who need your expertise.

Sources and References

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship